| 前收市價 | 0.3900 |
| 開市 | 0.2500 |
| 買盤 | 0.2500 |
| 賣出價 | 0.3500 |
| 拍板 | 2.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.2500 - 0.2500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 2.33k |
ZacksPacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
ZacksPacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksPacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
